YGL199C Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
YGL199C antibody; G1301 antibody; Putative uncharacterized protein YGL199C antibody
Target Names
YGL199C
Uniprot No.

Q&A

What types of YGL199C antibodies are available for research?

Several types of antibodies targeting different regions of the YGL199C protein are available for research purposes:

Antibody TypeTarget RegionHostApplicationsReference
Monoclonal combination (X-P53092-N)N-terminusMouseELISA, WB
Monoclonal combination (X-P53092-C)C-terminusMouseELISA, WB
Monoclonal combination (X-P53092-M)Middle regionMouseELISA, WB
Polyclonal (CSB-PA345254XA01SVG)Full recombinant proteinRabbitELISA, WB

Each monoclonal combination consists of multiple individual monoclonal antibodies targeting synthetic peptide antigens from the corresponding region of the YGL199C protein . The polyclonal antibody is antigen-affinity purified and stored in a buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative .

What are the recommended applications for YGL199C antibodies?

YGL199C antibodies have been validated primarily for the following applications:

  • Enzyme-Linked Immunosorbent Assay (ELISA): Both monoclonal and polyclonal antibodies show high ELISA titers, with monoclonal combinations demonstrating titers of approximately 10,000, corresponding to detection of approximately 1 ng of target protein .

  • Western Blotting (WB): The antibodies can be used for detection of YGL199C protein in yeast lysates via western blotting .

For other potential applications such as immunoprecipitation, immunohistochemistry, or flow cytometry, researchers should conduct validation experiments to confirm suitability, as these applications have not been explicitly verified in the available literature for YGL199C antibodies.

What controls should be included in experiments using YGL199C antibodies?

When designing experiments with YGL199C antibodies, the following controls are essential to ensure reliable and interpretable results:

  • Unstained cells: Include a sample without any antibody to establish baseline autofluorescence or background signal .

  • Negative cells: If available, include cells known not to express YGL199C to control for antibody specificity .

  • Isotype control: Use an antibody of the same class as your YGL199C antibody but with specificity for an irrelevant antigen not present in your samples. This controls for non-specific binding, particularly through Fc receptors .

  • Secondary antibody control: For indirect detection methods, include samples treated only with the labeled secondary antibody to assess non-specific binding of the secondary antibody .

  • Blocking controls: Evaluate the effectiveness of your blocking reagents by comparing blocked versus unblocked samples .

When working specifically with yeast cells, it's important to optimize cell preparation protocols to minimize autofluorescence, which can be particularly high in yeast due to their cell wall composition and metabolic state.

How should I optimize YGL199C antibody concentration for Western blotting?

Optimization of YGL199C antibody concentration for Western blotting requires a systematic titration approach:

  • Initial titration: Start with a range of dilutions (e.g., 1:500, 1:1000, 1:2000, 1:5000) based on the manufacturer's recommendation.

  • Sample preparation: Include both positive controls (yeast strains known to express YGL199C) and negative controls (deletion strains lacking YGL199C if available).

  • Optimization table: Document results in a structured format:

Antibody DilutionSignal IntensityBackgroundSignal-to-Noise RatioNotes
1:500
1:1000
1:2000
1:5000
  • Blocking optimization: Test different blocking agents (BSA, non-fat milk, commercial blockers) to determine which provides the best signal-to-noise ratio for YGL199C detection.

  • Incubation conditions: Evaluate both room temperature and 4°C incubations with varying durations to identify optimal binding conditions.

For monoclonal antibody combinations targeting YGL199C, begin with concentrations that correspond to the reported ELISA titers (approximately 1 ng detection sensitivity) and adjust based on empirical results.

How can I address non-specific binding issues with YGL199C antibodies?

Non-specific binding is a common challenge when working with antibodies against yeast proteins. Consider the following strategies to improve specificity:

  • Optimize blocking: Use 10% normal serum from the same host species as your labeled secondary antibody. Ensure the normal serum is NOT from the same host species as your primary antibody to avoid non-specific signals .

  • Pre-adsorption: For polyclonal antibodies, pre-adsorb against yeast lysates prepared from YGL199C deletion strains to remove antibodies that bind to other yeast proteins.

  • Cell preparation: Ensure high cell viability (>90%) before staining, as dead cells can contribute to high background scatter and false positive staining .

  • Buffer optimization: Include 0.1% sodium azide in PBS to prevent internalization of membrane antigens, and perform all steps on ice .

  • Antibody validation: Consider using epitope tagging approaches to validate antibody specificity, by expressing YGL199C with a known epitope tag and confirming co-localization of your YGL199C antibody with an antibody against the tag.

Can YGL199C antibodies be used for single-cell analysis of yeast populations?

While not specifically documented for YGL199C antibodies, single-cell analysis techniques have been successfully applied to yeast proteins using similar antibodies. To adapt these methods for YGL199C:

  • Cell wall considerations: Yeast cells require special preparation due to their rigid cell wall. For intracellular proteins like YGL199C, permeabilization protocols must be optimized using agents like zymolyase or lyticase followed by detergent treatment.

  • Single-cell isolation: Fluorescence-activated cell sorting (FACS) can be used to isolate individual yeast cells based on surface marker expression or other characteristics .

  • RT-PCR amplification: For correlating antibody binding with gene expression, single-cell RT-PCR can be performed using protocols similar to those described for human B cells , adapted for yeast:

    • Perform reverse transcription in 14 μl reactions using random hexamer primers

    • Use nested PCR to amplify specific transcripts

    • Consider combining antibody staining data with transcript analysis

  • Controls: Include unstained cells, isotype controls, and cells from YGL199C deletion strains to establish gating strategies and confirm antibody specificity.

The combination of antibody-based protein detection with single-cell transcriptomics can provide valuable insights into the heterogeneity of YGL199C expression within yeast populations.

How can I determine if my YGL199C antibody recognizes the native protein conformation?

Determining whether an antibody recognizes native protein conformations is critical for applications like immunoprecipitation. Consider these approaches:

  • Native vs. denatured comparison: Compare antibody binding to native protein (in non-denaturing immunoprecipitation) versus denatured protein (in Western blotting).

  • Immunoprecipitation validation: Perform immunoprecipitation followed by mass spectrometry to confirm capture of YGL199C and identify any co-precipitating partners.

  • Structural epitope mapping: For monoclonal antibodies targeting different regions (N-terminus, C-terminus, and M-terminus) , perform epitope mapping to determine the specific amino acid sequences recognized.

  • Cross-linking experiments: Use chemical cross-linking prior to cell lysis to stabilize protein complexes, then perform immunoprecipitation to identify YGL199C interaction partners in their native context.

The monoclonal antibody combinations available for YGL199C are designed to target specific regions , which may have different accessibility in the native versus denatured protein.

What approaches can be used to study YGL199C in the context of protein complexes?

While YGL199C is currently described as a putative uncharacterized protein , studying its interactions can help elucidate its function:

  • Co-immunoprecipitation: Use YGL199C antibodies to pull down the protein along with its binding partners, followed by mass spectrometry to identify the components of the complex.

  • Proximity labeling: Fuse YGL199C to a proximity labeling enzyme (BioID or APEX2) to identify proteins in its vicinity in living cells, then use YGL199C antibodies to confirm interactions.

  • Yeast two-hybrid screening: Complement antibody-based approaches with genetic screens to identify potential interaction partners.

  • Chromatin immunoprecipitation (ChIP): If YGL199C is suspected to interact with chromatin, ChIP using YGL199C antibodies can identify associated DNA regions.

  • Super-resolution microscopy: Combine YGL199C antibodies with fluorescently labeled antibodies against suspected interaction partners to visualize co-localization at sub-diffraction resolution.

When designing these experiments, it's important to consider that YGL199C's function remains uncharacterized, so exploratory approaches that don't rely on assumptions about its role may be most informative.

What are the recommended protocols for immunofluorescence using YGL199C antibodies in yeast cells?

Immunofluorescence in yeast requires specialized protocols due to the cell wall. While not specifically documented for YGL199C, the following protocol can be adapted:

  • Cell fixation and spheroplasting:

    • Fix cells with 3.7% formaldehyde for 30 minutes at room temperature

    • Wash 3× with PBS

    • Digest cell wall with zymolyase or lyticase in sorbitol buffer (1.2M sorbitol, 0.1M potassium phosphate, pH 7.5) for 20-30 minutes at 30°C

    • Monitor spheroplasting microscopically

  • Permeabilization and blocking:

    • Permeabilize with 0.1% Triton X-100 for 5 minutes

    • Block with 1% BSA and 0.1% Tween-20 in PBS for 30 minutes

  • Antibody incubation:

    • Primary antibody: Start with 1:100 to 1:500 dilution of YGL199C antibody in blocking buffer

    • Incubate overnight at 4°C

    • Wash 3× with PBS + 0.1% Tween-20

    • Secondary antibody: Use appropriate fluorophore-conjugated secondary at 1:1000 dilution

    • Incubate 1 hour at room temperature in the dark

    • Wash 3× with PBS + 0.1% Tween-20

  • Mounting and imaging:

    • Mount with anti-fade medium containing DAPI

    • Image using confocal or wide-field fluorescence microscopy

Optimization is essential, as the precise localization pattern of YGL199C is not well documented. Include appropriate controls at each step to validate specificity.

How should I design a flow cytometry experiment to analyze YGL199C expression in yeast populations?

Flow cytometry with yeast requires special considerations. Here's a protocol framework for YGL199C analysis:

  • Sample preparation:

    • Culture yeast to desired growth phase

    • Fix with 3.7% formaldehyde (30 minutes at room temperature)

    • Wash and digest cell wall as described for immunofluorescence

    • Adjust cell concentration to 10^5-10^6 cells/ml to avoid clogging the flow cell

  • Staining protocol:

    • Block with 10% serum from same host as secondary antibody

    • Incubate with YGL199C primary antibody (start with 1:100 dilution)

    • Wash 2× with PBS + 0.1% sodium azide

    • Incubate with fluorophore-conjugated secondary antibody

    • Wash 2× with PBS + 0.1% sodium azide

  • Essential controls:

    • Unstained cells to establish autofluorescence baseline

    • Secondary antibody only to assess non-specific binding

    • Isotype control to evaluate Fc receptor binding

    • YGL199C deletion strain (if available) as negative control

  • Gating strategy:

    • Gate on singlet yeast cells using FSC-A vs. FSC-H

    • Exclude dead cells using viability dye

    • Analyze YGL199C expression within viable single-cell population

  • Data analysis considerations:

    • Report median fluorescence intensity rather than mean, as yeast populations often show non-normal distributions

    • Quantify the percentage of positive cells relative to appropriate negative controls

All flow cytometry steps should be performed on ice with buffers containing 0.1% sodium azide to prevent internalization of surface antigens .

How can YGL199C antibodies contribute to understanding yeast protein dynamics during stationary phase?

Research has indicated that YGL199C may be involved in processes related to stationary phase in yeast . Antibodies can help investigate these dynamics:

  • Temporal expression analysis: Use YGL199C antibodies to track protein expression levels across different growth phases, particularly during transition to stationary phase.

  • Subcellular localization changes: Combine fractionation techniques with Western blotting using YGL199C antibodies to monitor potential relocalization during stationary phase.

  • Post-translational modifications: Use phospho-specific antibodies or combine standard YGL199C antibodies with techniques like Phos-tag gels to investigate regulation by phosphorylation during stationary phase.

  • Protein stability studies: Perform cycloheximide chase experiments and use YGL199C antibodies to assess protein half-life changes during different growth phases.

  • Stress response correlation: Analyze how YGL199C protein levels (detected by antibodies) correlate with stress responses typical of stationary phase, such as oxidative stress or nutrient limitation.

This approach could provide valuable insights into the function of this uncharacterized protein in yeast cellular responses to stationary phase conditions.

What methodological approaches can be combined with YGL199C antibodies for comprehensive functional analysis?

A multi-faceted approach combining antibody-based techniques with other methodologies can help elucidate YGL199C function:

  • Genetic-proteomic correlation:

    • Use YGL199C antibodies to quantify protein levels in wild-type and mutant strains

    • Correlate phenotypic changes in YGL199C deletion or overexpression strains with protein levels in different genetic backgrounds

  • Systematic interaction mapping:

    • Apply techniques like LIBRA-seq (Linking B-cell Receptor to Antigen Specificity through sequencing) adapted for yeast proteins

    • Combine with YGL199C antibody validation to confirm interactions

  • Structure-function analysis:

    • Use epitope mapping with the available monoclonal antibody combinations targeting different regions of YGL199C

    • Correlate antibody binding with functional domains identified through bioinformatic analysis

  • Evolutionary conservation study:

    • Use YGL199C antibodies to test cross-reactivity with homologous proteins in related yeast species

    • Correlate conservation of antibody epitopes with functional importance

  • Integration with genomic data:

    • Compare YGL199C protein levels (detected by antibodies) with transcriptomic data from RNA-seq

    • Analyze post-transcriptional regulation mechanisms

This integrative approach leverages the specificity of YGL199C antibodies while overcoming their limitations through complementary methodologies.

What are the key recommendations for successful experiments with YGL199C antibodies?

Based on the available information and general antibody best practices, researchers should:

  • Validate specificity: Test antibodies on samples from YGL199C deletion strains or through epitope tagging approaches.

  • Optimize conditions: Perform systematic titration and condition optimization for each application.

  • Include comprehensive controls: Follow the control recommendations detailed in section 2.1.

  • Document lot-to-lot variation: Keep detailed records of antibody performance across different lots, as antibody properties can vary.

  • Consider epitope accessibility: Use antibodies targeting different regions of YGL199C to ensure detection regardless of potential structural occlusion.

  • Share protocols: Contribute optimized protocols to community resources to advance collective understanding of this uncharacterized protein.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.